Australian Broker Call

Produced and copyrighted by at www.fnarena.com

December 13, 2018

Access Broker Call Report Archives here

COMPANIES DISCUSSED IN THIS ISSUE

Click on symbol for fast access.

The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).

Last Updated: 05:00 PM

Your daily news report on the latest recommendation, valuation, forecast and opinion changes.

This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.

For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE

Today's Upgrades and Downgrades
ABC - ADELAIDE BRIGHTON Upgrade to Neutral from Sell Citi
BPT - BEACH ENERGY Upgrade to Neutral from Sell Citi
EVN - EVOLUTION MINING Downgrade to Underperform from Neutral Credit Suisse
SBM - ST BARBARA Downgrade to Underperform from Neutral Credit Suisse
SHL - SONIC HEALTHCARE Upgrade to Buy from Neutral Citi
ABC  ADELAIDE BRIGHTON LIMITED

Building Products & Services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.57

Citi rates ABC as Upgrade to Neutral from Sell (3) -

Citi observes the shares have fallen -38% from highs in early July. The housing cycle may have peaked but the broker believes the company's exposure to infrastructure and non-residential markets will provide a meaningful offset.

While the company has downgraded net profit guidance by -6%, the broker believes the factors are temporary. The broker cannot rule out speculation regarding the logic of a merger between Adelaide Brighton and privately-owned Barro, which is owned by the company's largest shareholder, the Barro family.

Citi upgrades to Neutral from Sell, believing the stock has retreated to fair value. Target is reduced to $4.70 from $5.50.

Target price is $4.70 Current Price is $4.57 Difference: $0.13
If ABC meets the Citi target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $4.89, suggesting upside of 7.1% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY18:

Citi forecasts a full year FY18 dividend of 27.50 cents and EPS of 29.30 cents.
At the last closing share price the estimated dividend yield is 6.02%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.60.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 29.2, implying annual growth of 4.3%.

Current consensus DPS estimate is 27.0, implying a prospective dividend yield of 5.9%.

Current consensus EPS estimate suggests the PER is 15.7.

Forecast for FY19:

Citi forecasts a full year FY19 dividend of 29.50 cents and EPS of 30.60 cents.
At the last closing share price the estimated dividend yield is 6.46%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.93.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.9, implying annual growth of 9.2%.

Current consensus DPS estimate is 27.8, implying a prospective dividend yield of 6.1%.

Current consensus EPS estimate suggests the PER is 14.3.

Market Sentiment: -0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AMC  AMCOR LIMITED

Paper & Packaging

More Research Tools In Stock Analysis - click HERE

Overnight Price: $13.24

Ord Minnett rates AMC as Accumulate (2) -

Ord Minnett observes North American beverage volumes are a key focal point for the business. Beverage data by Nielsen points to continued volume weakness over the four weeks to December 1.

Notably, Kraft Heinz, the largest customer of Bemis, accounting for 10% of sales, has experienced an improvement in recent months.

North American beverages represent around 17% of Amcor's group revenue. Ord Minnett expects volumes to increase by 2% in FY19 before settling at growth of 1%.

Accumulate rating and $15.50 target maintained.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $15.50 Current Price is $13.24 Difference: $2.26
If AMC meets the Ord Minnett target it will return approximately 17% (excluding dividends, fees and charges).

Current consensus price target is $15.23, suggesting upside of 15.0% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Ord Minnett forecasts a full year FY19 dividend of 59.84 cents and EPS of 78.05 cents.
At the last closing share price the estimated dividend yield is 4.52%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 86.5, implying annual growth of N/A.

Current consensus DPS estimate is 63.2, implying a prospective dividend yield of 4.8%.

Current consensus EPS estimate suggests the PER is 15.3.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 dividend of 62.44 cents and EPS of 92.36 cents.
At the last closing share price the estimated dividend yield is 4.72%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.33.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 97.2, implying annual growth of 12.4%.

Current consensus DPS estimate is 68.9, implying a prospective dividend yield of 5.2%.

Current consensus EPS estimate suggests the PER is 13.6.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AVG  AUSTRALIAN VINTAGE PTY LTD

Food, Beverages & Tobacco

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.50

Morgans rates AVG as Initiation of coverage with Add (1) -

Australian Vintage is one of Australia's largest vertically-integrated wine companies and Morgans initiates coverage with an Add rating and $0.64 target.

The company operates two wineries, in Sunraysia and the Hunter Valley and owns six vineyards, while leasing an additional four.

The business has strong positions with a number of retailers and wholesalers throughout Australia and the UK and is intent on growing sales in Europe, North America and Asia.

The broker forecasts an increase in net profit in FY19 of 15.3%.

Target price is $0.64 Current Price is $0.50 Difference: $0.14
If AVG meets the Morgans target it will return approximately 28% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY19:

Morgans forecasts a full year FY19 dividend of 1.70 cents and EPS of 3.10 cents.
At the last closing share price the estimated dividend yield is 3.40%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.13.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 2.40 cents and EPS of 4.30 cents.
At the last closing share price the estimated dividend yield is 4.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.63.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

BPT  BEACH ENERGY LIMITED

Crude Oil

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.51

Citi rates BPT as Upgrade to Neutral from Sell (3) -

Citi downgrades oil price forecasts and now expects Brent oil at U $60/bbl for 2018 and US$55/bbl for 2019. The broker maintains a neutral view on the sector but concedes there may be deep value emerging in some names.

Following the recent decline in the share price the broker now considers Beach Energy fair value and upgrades to Neutral from Sell. Target is reduced to $1.62 from $1.70.

Target price is $1.62 Current Price is $1.51 Difference: $0.11
If BPT meets the Citi target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $1.87, suggesting upside of 23.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Citi forecasts a full year FY19 EPS of 17.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.88.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 21.0, implying annual growth of 5.8%.

Current consensus DPS estimate is 4.5, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 7.2.

Forecast for FY20:

Citi forecasts a full year FY20 EPS of 16.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.44.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 21.7, implying annual growth of 3.3%.

Current consensus DPS estimate is 4.8, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 7.0.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CIP  CENTURIA INDUSTRIAL REIT

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.83

Morgans rates CIP as Hold (3) -

The company has acquired two industrial assets in Queensland and Western Australia for $54.4m, to be partly funded by a non-renounceable rights issue and debt.

Morgans notes the portfolio is now valued at $1.1bn, with occupancy around 94.6% and a weighted average lease expiry of around 4.7 years.

The broker retains a Hold rating and raises the target to $2.72 from $2.71.

Target price is $2.72 Current Price is $2.83 Difference: minus $0.11 (current price is over target).
If CIP meets the Morgans target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).

The company's fiscal year ends in June.

Forecast for FY19:

Morgans forecasts a full year FY19 dividend of 18.40 cents and EPS of 18.90 cents.
At the last closing share price the estimated dividend yield is 6.50%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.97.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 18.60 cents and EPS of 19.40 cents.
At the last closing share price the estimated dividend yield is 6.57%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.59.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

EVN  EVOLUTION MINING LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.29

Credit Suisse rates EVN as Downgrade to Underperform from Neutral (5) -

Credit Suisse believes, while Evolution Mining is a high-quality gold producer with a diverse portfolio, the stock is expensive.

A strong operating performance has meant acquisitions have been rapidly paid for, which has positioned the business to prosper under a range of gold price scenarios.

Still, on the basis of valuation, the broker downgrades to Underperform from Neutral. Target is reduced to $2.55 from $2.65.

Target price is $2.55 Current Price is $3.29 Difference: minus $0.74 (current price is over target).
If EVN meets the Credit Suisse target it will return approximately minus 22% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $3.04, suggesting downside of -7.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Credit Suisse forecasts a full year FY19 dividend of 9.00 cents and EPS of 12.34 cents.
At the last closing share price the estimated dividend yield is 2.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.6, implying annual growth of -12.7%.

Current consensus DPS estimate is 7.6, implying a prospective dividend yield of 2.3%.

Current consensus EPS estimate suggests the PER is 24.2.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 10.00 cents and EPS of 15.74 cents.
At the last closing share price the estimated dividend yield is 3.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.90.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 18.8, implying annual growth of 38.2%.

Current consensus DPS estimate is 9.8, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 17.5.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

HUB  HUB24 LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $13.20

Citi rates HUB as Initiation of coverage with Neutral (3) -

Citi expects a structural shift to specialist platform providers will accelerate and the company will more than double its market share over the next five years.

The broker initiates coverage with a Neutral rating, because upside in market share is envisaged but also downside to margins. The target is $14.25.

The broker envisages upside to market share forecasts if vertically-integrated operators are restricted by regulation and aligned advisers depart at a faster rate.

Target price is $14.25 Current Price is $13.20 Difference: $1.05
If HUB meets the Citi target it will return approximately 8% (excluding dividends, fees and charges).

Current consensus price target is $13.84, suggesting upside of 4.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Citi forecasts a full year FY19 dividend of 9.00 cents and EPS of 17.80 cents.
At the last closing share price the estimated dividend yield is 0.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 74.16.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.0, implying annual growth of 38.5%.

Current consensus DPS estimate is 9.0, implying a prospective dividend yield of 0.7%.

Current consensus EPS estimate suggests the PER is 77.6.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 15.30 cents and EPS of 29.60 cents.
At the last closing share price the estimated dividend yield is 1.16%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 44.59.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.5, implying annual growth of 67.6%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 1.2%.

Current consensus EPS estimate suggests the PER is 46.3.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

KLL  KALIUM LAKES LIMITED

Mining

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.35

Macquarie rates KLL as Outperform (1) -

Macquarie observes Beyondie continues to advance rapidly. Early works and FEED are progressing and the company will install camp facilities early in 2019. Financing discussions are continuing.

An offtake agreement with a German fertiliser producer is nearing finalisation, with due diligence and review of the bankable feasibility study being completed. Macquarie also believes further optimisation from FEED activity and recovery enhancements are likely.

The broker maintains an Outperform rating and $0.75 target.

Target price is $0.75 Current Price is $0.35 Difference: $0.4
If KLL meets the Macquarie target it will return approximately 114% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY19:

Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 2.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 14.58.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 1.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 20.59.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NCM  NEWCREST MINING LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $20.63

Credit Suisse rates NCM as Neutral (3) -

Newcrest and partner Harmony have signed an MOU with the PNG government that affirms the intention to proceed with Wafi Golpu. The MOU allows the planned work for 2019 to proceed.

Credit Suisse notes prior guidance had indicated the company's share of expenditure for the year would be US$40-45m and this remains likely to be the case.

Newcrest currently has a 50% equity share, which could be diluted to 35% if the PNG government takes up its right to 30%.

Credit Suisse maintains a Neutral rating and $20.30 target.

Target price is $20.30 Current Price is $20.63 Difference: minus $0.33 (current price is over target).
If NCM meets the Credit Suisse target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $21.31, suggesting upside of 3.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Credit Suisse forecasts a full year FY19 dividend of 31.97 cents and EPS of 89.86 cents.
At the last closing share price the estimated dividend yield is 1.55%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.96.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 90.8, implying annual growth of N/A.

Current consensus DPS estimate is 25.0, implying a prospective dividend yield of 1.2%.

Current consensus EPS estimate suggests the PER is 22.7.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 31.97 cents and EPS of 91.74 cents.
At the last closing share price the estimated dividend yield is 1.55%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.49.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 113.8, implying annual growth of 25.3%.

Current consensus DPS estimate is 31.7, implying a prospective dividend yield of 1.5%.

Current consensus EPS estimate suggests the PER is 18.1.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

NWL  NETWEALTH GROUP LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $8.00

Citi rates NWL as Initiation of coverage with Neutral (3) -

Citi expects a structural shift to specialist platform providers will accelerate and the company will more than double its market share over the next five years.

The broker initiates coverage with a Neutral rating, because upside in market share is envisaged but also downside to margins. The target is $8.10.

The broker envisages upside to market share forecasts if vertically-integrated operators are restricted by regulation and aligned advisers depart at a faster rate.

Target price is $8.10 Current Price is $8.00 Difference: $0.1
If NWL meets the Citi target it will return approximately 1% (excluding dividends, fees and charges).

Current consensus price target is $7.90, suggesting downside of -1.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Citi forecasts a full year FY19 dividend of 11.10 cents and EPS of 16.00 cents.
At the last closing share price the estimated dividend yield is 1.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 50.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 15.2, implying annual growth of 80.1%.

Current consensus DPS estimate is 11.2, implying a prospective dividend yield of 1.4%.

Current consensus EPS estimate suggests the PER is 52.6.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 14.50 cents and EPS of 20.00 cents.
At the last closing share price the estimated dividend yield is 1.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 40.00.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 19.2, implying annual growth of 26.3%.

Current consensus DPS estimate is 14.3, implying a prospective dividend yield of 1.8%.

Current consensus EPS estimate suggests the PER is 41.7.

Market Sentiment: -0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PAN  PANORAMIC RESOURCES LIMITED

Nickel

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.38

Morgans rates PAN as Initiation of coverage with Add (1) -

The company's Savannah project in Western Australia is being re-started. The mine infrastructure has been kept in good standing and Morgans notes the company's long-established knowledge of operations.

The broker initiates coverage with an Add rating and $0.70 target, believing the stock offers modest upside leverage versus other base metal developers, with correspondingly lower risk given the mine's proven operations, de-risked geology and funding certainty.

Target price is $0.70 Current Price is $0.38 Difference: $0.32
If PAN meets the Morgans target it will return approximately 84% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY19:

Morgans forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 0.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 126.67.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of 4.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.27.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

QBE  QBE INSURANCE GROUP LIMITED

Insurance

More Research Tools In Stock Analysis - click HERE

Overnight Price: $10.18

Deutsche Bank rates QBE as Hold (3) -

QBE has announced a new reinsurance program for 2019. Exposure is reduced to large single events but increased to medium-sized events.

Deutsche Bank observes the change will result in a $100m improvement in the regulatory capital position. However, the lower level of horizontal cover increases the P&L volatility.

Hold rating and $11 target are maintained.

Target price is $11.00 Current Price is $10.18 Difference: $0.82
If QBE meets the Deutsche Bank target it will return approximately 8% (excluding dividends, fees and charges).

Current consensus price target is $12.15, suggesting upside of 19.4% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY18:

Current consensus EPS estimate is 78.4, implying annual growth of N/A.

Current consensus DPS estimate is 63.1, implying a prospective dividend yield of 6.2%.

Current consensus EPS estimate suggests the PER is 13.0.

Forecast for FY19:

Current consensus EPS estimate is 88.8, implying annual growth of 13.3%.

Current consensus DPS estimate is 74.0, implying a prospective dividend yield of 7.3%.

Current consensus EPS estimate suggests the PER is 11.5.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.8

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

QUB  QUBE HOLDINGS LIMITED

Transportation & Logistics

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.58

UBS rates QUB as Neutral (3) -

UBS estimates $600m will be spent at Moorebank in the next three years and the company has sufficient balance sheet capacity, supported by a more positive outlook for Patrick.

The broker observes delays to Moorebank and pressure on stevedore profitability have been offset by a solid performance in the operating division and the potential for a special dividend.

Additionally, NSW Ports investment in rail, and increased infrastructure levies by DP World, are likely to improve investor sentiment.

The broker makes minor downgrades to estimates for earnings per share, given the stock has outperformed the market since beginning of November.

The broker continues to believe FY18 will be the cyclical low point and the shares are fairly valued at current levels. Neutral maintained. Target is reduced to $2.75 from $2.80.

Target price is $2.75 Current Price is $2.58 Difference: $0.17
If QUB meets the UBS target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $2.72, suggesting upside of 5.3% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

UBS forecasts a full year FY19 dividend of 5.50 cents and EPS of 8.70 cents.
At the last closing share price the estimated dividend yield is 2.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 29.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.6, implying annual growth of 61.7%.

Current consensus DPS estimate is 5.5, implying a prospective dividend yield of 2.1%.

Current consensus EPS estimate suggests the PER is 33.9.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 5.50 cents and EPS of 10.30 cents.
At the last closing share price the estimated dividend yield is 2.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 8.8, implying annual growth of 15.8%.

Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 2.4%.

Current consensus EPS estimate suggests the PER is 29.3.

Market Sentiment: -0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SBM  ST BARBARA LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.24

Credit Suisse rates SBM as Downgrade to Underperform from Neutral (5) -

Credit Suisse believes the business is performing extremely well, with a record performance across both assets. The challenges lie with identifying another acquisition target that would be a good fit for the portfolio.

As a result of its corporate strategy, St Barbara has built various equity positions in Australian-listed gold companies, but the broker observes these are at the early stage and reliant on significant exploration success to define a development.

Rating is downgraded to Underperform from Neutral as the stock is considered fully priced. Target is raised to $3.90 from $3.85

Target price is $3.90 Current Price is $4.24 Difference: minus $0.34 (current price is over target).
If SBM meets the Credit Suisse target it will return approximately minus 8% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $4.28, suggesting upside of 0.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Credit Suisse forecasts a full year FY19 dividend of 7.92 cents and EPS of 26.39 cents.
At the last closing share price the estimated dividend yield is 1.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.07.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.8, implying annual growth of -28.2%.

Current consensus DPS estimate is 9.5, implying a prospective dividend yield of 2.2%.

Current consensus EPS estimate suggests the PER is 13.3.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 8.48 cents and EPS of 28.28 cents.
At the last closing share price the estimated dividend yield is 2.00%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.99.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.6, implying annual growth of 8.8%.

Current consensus DPS estimate is 11.1, implying a prospective dividend yield of 2.6%.

Current consensus EPS estimate suggests the PER is 12.3.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SHL  SONIC HEALTHCARE LIMITED

Healthcare services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $21.76

Citi rates SHL as Upgrade to Buy from Neutral (1) -

The company will acquire US-based Aurora Diagnostics, funded by a $600m placement, up to $100m in a share purchase plan and debt. The transaction appears a good strategic fit, Citi suggests, and could be transformational for the US business over time.

Still, the broker questions whether raising equity at the current point in time is appropriate, given the company has the balance sheet capacity to fully fund the deal with debt. There is also limited visibility on the business, as it was acquired for private equity.

Citi upgrades to Buy from Neutral on valuation. Target is reduced to $25.25 from $26.25.

Target price is $25.25 Current Price is $21.76 Difference: $3.49
If SHL meets the Citi target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Citi forecasts a full year FY19 dividend of 84.00 cents and EPS of 117.30 cents.
At the last closing share price the estimated dividend yield is 3.86%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.55.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 92.00 cents and EPS of 126.20 cents.
At the last closing share price the estimated dividend yield is 4.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.24.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Credit Suisse rates SHL as Neutral (3) -

Sonic Healthcare will acquire Aurora Diagnostics for US$540m. Credit Suisse notes the US anatomical pathology market is highly fragmented and growth is being driven by the increasing prevalence of chronic diseases, an ageing population and increased healthcare expenditure.

The broker envisages potential for revenue synergies, with the company leveraging its new scale across the US hospital market. The broker maintains a Neutral rating and raises the target to $24.70 from $23.00.

Target price is $24.70 Current Price is $21.76 Difference: $2.94
If SHL meets the Credit Suisse target it will return approximately 14% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Credit Suisse forecasts a full year FY19 dividend of 83.00 cents and EPS of 116.00 cents.
At the last closing share price the estimated dividend yield is 3.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.76.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 91.00 cents and EPS of 123.00 cents.
At the last closing share price the estimated dividend yield is 4.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.69.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Deutsche Bank rates SHL as Buy (1) -

Deutsche Bank believes the acquisition of  Aurora Diagnostics makes sense but is wary of challenging US market conditions and the sustainability of Aurora's margin.

The transaction is expected to expand the US business and increase exposure to the fragmented anatomical pathology market.

Buy rating maintained. Target is $29.56.

Target price is $29.56 Current Price is $21.76 Difference: $7.8
If SHL meets the Deutsche Bank target it will return approximately 36% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Macquarie rates SHL as Neutral (3) -

The company will acquire Aurora Diagnostics, a US-based anatomical pathology service provider. Macquarie believes this is a strategically sound acquisition that will provide near-term accretion and the potential for growth over the longer term.

The broker's investment view balances reimbursement pressure in both the US and Germany, with potential for acquisitions and lower Australian collection centre rent costs.

Neutral rating maintained. Target is raised to $25.20 from $24.30.

Target price is $25.20 Current Price is $21.76 Difference: $3.44
If SHL meets the Macquarie target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Macquarie forecasts a full year FY19 dividend of 84.50 cents and EPS of 118.90 cents.
At the last closing share price the estimated dividend yield is 3.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 90.20 cents and EPS of 125.10 cents.
At the last closing share price the estimated dividend yield is 4.15%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.39.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates SHL as Overweight (1) -

The company has acquired Aurora Diagnostics, a US-based pathology business with pro forma revenue of US$310m and EBITDA of US$59m.

Morgan Stanley notes, as anatomical pathology is not subject to funding cuts, the deal dilutes some of the top-line risk in the US and increases the company's US business representation to 28%.

The purchase price is US$540m, to be funded by a placement and bridging facility. Expected synergies are derived from cross selling opportunities between clinical and anatomical pathology.

Overweight. Target is $27.70. Industry view is In-Line.

Target price is $27.70 Current Price is $21.76 Difference: $5.94
If SHL meets the Morgan Stanley target it will return approximately 27% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Morgan Stanley forecasts a full year FY19 dividend of 85.20 cents and EPS of 120.00 cents.
At the last closing share price the estimated dividend yield is 3.92%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.13.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 93.20 cents and EPS of 131.00 cents.
At the last closing share price the estimated dividend yield is 4.28%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.61.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgans rates SHL as Add (1) -

The company has increased its US footprint, purchasing Aurora Diagnostics for US$540m. Morgans believes the multiple paid is at the high end, although synergies include revenue expansion opportunities and the company is adding significant scale in a fragmented market.

The broker increases US sales projections and operating margins, leading to increases in earnings per share of up to 3.1%. Add rating maintained. Target is reduced to $27.95 from $28.70.

Target price is $27.95 Current Price is $21.76 Difference: $6.19
If SHL meets the Morgans target it will return approximately 28% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

Morgans forecasts a full year FY19 dividend of 89.00 cents and EPS of 121.00 cents.
At the last closing share price the estimated dividend yield is 4.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

Morgans forecasts a full year FY20 dividend of 94.00 cents and EPS of 130.00 cents.
At the last closing share price the estimated dividend yield is 4.32%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates SHL as Neutral (3) -

Sonic Healthcare has announced the acquisition of Aurora Diagnostics for US$540m to be funded by a fully underwritten institutional placement, a separate share purchase plan and cash/debt facilities.

The acquisition significantly the increases the company's scale in anatomical pathology services and expands the US footprint into five new states.

UBS incorporates the pro forma earnings into its model, which drives a 7.3% increase to FY19 revenue and 11.4% to net profit. Earnings per share estimates lift 2-3% across the forecast period.

UBS maintains a Neutral rating and reduces the target to $23.20 from $23.50.

Target price is $23.20 Current Price is $21.76 Difference: $1.44
If SHL meets the UBS target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $26.02, suggesting upside of 19.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY19:

UBS forecasts a full year FY19 dividend of 86.00 cents and EPS of 115.00 cents.
At the last closing share price the estimated dividend yield is 3.95%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.92.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 118.1, implying annual growth of 4.9%.

Current consensus DPS estimate is 85.4, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 18.4.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 92.00 cents and EPS of 123.00 cents.
At the last closing share price the estimated dividend yield is 4.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.69.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 126.2, implying annual growth of 6.9%.

Current consensus DPS estimate is 91.8, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 17.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Today's Price Target Changes
Company Broker New Target Prev Target Change
ABC ADELAIDE BRIGHTON Citi 4.70 5.50 -14.55%
AQG ALACER GOLD Credit Suisse 5.05 5.30 -4.72%
BPT BEACH ENERGY Citi 1.62 1.70 -4.71%
CIP CENTURIA INDUSTRIAL REIT Morgans 2.72 2.71 0.37%
EVN EVOLUTION MINING Credit Suisse 2.55 2.65 -3.77%
IGO INDEPENDENCE GROUP Credit Suisse 3.65 3.95 -7.59%
ORG ORIGIN ENERGY Citi 8.23 8.52 -3.40%
OSH OIL SEARCH Citi 7.33 7.56 -3.04%
OZL OZ MINERALS Credit Suisse 9.00 9.50 -5.26%
QUB QUBE HOLDINGS UBS 2.75 2.80 -1.79%
SBM ST BARBARA Credit Suisse 3.90 3.85 1.30%
SFR SANDFIRE Credit Suisse 6.75 6.70 0.75%
SHL SONIC HEALTHCARE Citi 25.25 26.25 -3.81%
Credit Suisse 24.70 23.00 7.39%
Deutsche Bank 29.56 28.10 5.20%
Macquarie 25.20 24.30 3.70%
Morgans 27.95 28.70 -2.61%
UBS 23.20 23.50 -1.28%
SXY SENEX ENERGY Citi 0.47 0.51 -7.84%
WPL WOODSIDE PETROLEUM Citi 31.85 32.91 -3.22%
WSA WESTERN AREAS Credit Suisse 2.65 3.00 -11.67%
Summaries
ABC ADELAIDE BRIGHTON Upgrade to Neutral from Sell - Citi Overnight Price $4.57
AMC AMCOR Accumulate - Ord Minnett Overnight Price $13.24
AVG AUST VINTAGE Initiation of coverage with Add - Morgans Overnight Price $0.50
BPT BEACH ENERGY Upgrade to Neutral from Sell - Citi Overnight Price $1.51
CIP CENTURIA INDUSTRIAL REIT Hold - Morgans Overnight Price $2.83
EVN EVOLUTION MINING Downgrade to Underperform from Neutral - Credit Suisse Overnight Price $3.29
HUB HUB24 Initiation of coverage with Neutral - Citi Overnight Price $13.20
KLL KALIUM LAKES Outperform - Macquarie Overnight Price $0.35
NCM NEWCREST MINING Neutral - Credit Suisse Overnight Price $20.63
NWL NETWEALTH GROUP Initiation of coverage with Neutral - Citi Overnight Price $8.00
PAN PANORAMIC RESOURCES Initiation of coverage with Add - Morgans Overnight Price $0.38
QBE QBE INSURANCE Hold - Deutsche Bank Overnight Price $10.18
QUB QUBE HOLDINGS Neutral - UBS Overnight Price $2.58
SBM ST BARBARA Downgrade to Underperform from Neutral - Credit Suisse Overnight Price $4.24
SHL SONIC HEALTHCARE Upgrade to Buy from Neutral - Citi Overnight Price $21.76
Neutral - Credit Suisse Overnight Price $21.76
Buy - Deutsche Bank Overnight Price $21.76
Neutral - Macquarie Overnight Price $21.76
Overweight - Morgan Stanley Overnight Price $21.76
Add - Morgans Overnight Price $21.76
Neutral - UBS Overnight Price $21.76
RATING SUMMARY
Rating No. Of Recommendations
1. Buy

7

2. Accumulate

1

3. Hold

11

5. Sell

2

Thursday 13 December 2018

Access Broker Call Report Archives here

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.